ID: ALA2018988

Max Phase: Preclinical

Molecular Formula: C25H21N5OS

Molecular Weight: 439.54

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C(Cn1c(CSc2ccccc2)nc2ccccc21)NN=Cc1c[nH]c2ccccc12

Standard InChI:  InChI=1S/C25H21N5OS/c31-25(29-27-15-18-14-26-21-11-5-4-10-20(18)21)16-30-23-13-7-6-12-22(23)28-24(30)17-32-19-8-2-1-3-9-19/h1-15,26H,16-17H2,(H,29,31)

Standard InChI Key:  GLMBLYJZEORPDP-UHFFFAOYSA-N

Associated Targets(Human)

A549 127892 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

HCT-116 91556 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

HepG2 196354 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

PC-9 1037 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

A-375 9258 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 439.54Molecular Weight (Monoisotopic): 439.1467AlogP: 4.96#Rotatable Bonds: 7
Polar Surface Area: 75.07Molecular Species: NEUTRALHBA: 5HBD: 2
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 11.66CX Basic pKa: 4.91CX LogP: 4.51CX LogD: 4.51
Aromatic Rings: 5Heavy Atoms: 32QED Weighted: 0.21Np Likeness Score: -1.83

References

1. Liu T, Sun C, Xing X, Jing L, Tan R, Luo Y, Huang W, Song H, Li Z, Zhao Y..  (2012)  Synthesis and evaluation of 2-[2-(phenylthiomethyl)-1H-benzo[d] imidazol-1-yl)acetohydrazide derivatives as antitumor agents.,  22  (9): [PMID:22483608] [10.1016/j.bmcl.2012.03.061]

Source